US Patent Issued to University of Massachusetts on Feb. 17 for "Targeting Nrip1 to alleviate metabolic disease" (Massachusetts Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,553,039, issued on Feb. 17, was assigned to University of Massachusetts (Westborough, Mass.).

"Targeting Nrip1 to alleviate metabolic disease" was invented by Michael P. Czech (Westborough, Mass.), Emmanouela Tsagkaraki (Worcester, Mass.), Sarah M. Nicoloro (Holden, Mass.) and Silvia Corvera (Westborough, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods and compositions for disrupting expression of nuclear receptor interacting protein 1 (Nrip1) in adipose cells, and methods of use of such adipose cells for treating, or reducing risk of, a condition associated with an elevated body mass index (BMI)."

The patent was filed ...